
CureVac N.V. — Investor Relations & Filings
CureVac N.V. is a global biopharmaceutical company that develops transformative medicines based on messenger ribonucleic acid (mRNA). With over two decades of experience, the company leverages its proprietary mRNA technology platform to enable the human body to produce its own therapeutic proteins to fight a wide range of diseases. CureVac's clinical development pipeline is focused on creating prophylactic vaccines for infectious diseases, as well as therapies in oncology and for rare diseases. The company collaborates with partners to advance its portfolio of mRNA-based candidates.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 15-12G | 2026-01-16 | English | |
| S-8 POS | 2026-01-07 | English | |
| Delisting Announcement 2026 | 2026-01-06 | English | |
| 6-K | 2026-01-06 | English | |
| SC 14D9/A | 2025-12-18 | English | |
| Major Shareholding Notification 2025 | 2025-12-12 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
4 filings
| |||||
| 13250193 | 15-12G | 2026-01-16 | English | ||
| 13250194 | S-8 POS | 2026-01-07 | English | ||
| 13250195 | Delisting Announcement 2026 | 2026-01-06 | English | ||
| 13250196 | 6-K | 2026-01-06 | English | ||
|
2025
11 filings
| |||||
| 13250197 | SC 14D9/A | 2025-12-18 | English | ||
| 13250198 | Major Shareholding Notification 2025 | 2025-12-12 | English | ||
| 13250199 | Major Shareholding Notification 2025 | 2025-12-12 | English | ||
| 13250200 | Major Shareholding Notification 2025 | 2025-12-12 | English | ||
| 13250201 | SC 14D9/A | 2025-12-05 | English | ||
| 13250202 | SC 14D9/A | 2025-11-26 | English | ||
| 13250203 | FORM 6-K | 2025-11-26 | English | ||
| 13250204 | SC 14D9/A | 2025-11-25 | English | ||
| 13250205 | SC 14D9/A | 2025-11-24 | English | ||
| 13250206 | FORM 6-K | 2025-11-24 | English | ||
| 13250207 | FORM 6-K | 2025-10-27 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Cellectis
Develops allogeneic, or 'off-the-shelf', CAR T-cell immunot…
|
ALCLS | FR | Manufacturing |
|
Cellid Co., Ltd.
Develops immunotherapeutic vaccines for cancer and infectio…
|
299660 | KR | Manufacturing |
|
Cellromax Science Co., Ltd.
Researches and develops health foods, derma-cosmetics, and …
|
471820 | KR | Manufacturing |
|
CellSeed Inc.
Develops and commercializes cell sheet engineering for rege…
|
7776 | JP | Manufacturing |
|
Celltrion, Inc.
Biopharmaceutical firm developing biosimilars for autoimmun…
|
068270 | KR | Manufacturing |
|
Celltrion Pharm Inc.
Manufactures and supplies chemical pharmaceuticals and bios…
|
068760 | KR | Manufacturing |
|
CELLUMED CO., LTD.
Develops and manufactures medical devices, tissue grafts, a…
|
049180 | KR | Manufacturing |
|
Celon Pharma S.A.
An integrated pharmaceutical company researching and manufa…
|
CLN | PL | Manufacturing |
|
Celularity Inc
Develops allogeneic cell therapies and biomaterials from th…
|
CELU | US | Manufacturing |
|
Cenra Inc.
Diversified healthcare enterprise providing R&D, manufactur…
|
3716 | TW | Manufacturing |
CureVac N.V. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32086/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32086 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32086 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32086 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32086}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CureVac N.V. (id: 32086)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.